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The presence of bacteria within epithelial-lined compartments, such as the lung, elicits rapid recruitment of
innate immune cells. In this issue of Cell Host & Microbe, Chun and Prince (2009) report that epithelial cells
facilitate this process by reorganizing their intercellular junctions to enhance immune cell transmigration.Polymorphonuclear leukocytes (PMNs),
or neutrophils, are the first inflammatory
cells to be recruited in response to infec-
tion or tissue damage. The significant
role played by these innate immune cells
is emphasized by the fact that PMN defi-
ciency, whether due to genetic defects,
disease, or therapy, is associated with
increased risk of infection. Such infec-
tions often involve the lungs, which are
continuously exposed to airborne
microbes. Thus, the ability of PMNs to
access the airspace in order to contain
and destroy potential pathogens is critical
to health.
To reach the alveolar airspaces, or any
other tissue site, PMNs must first migrate
from the blood stream across the vascular
endothelium. The process of transendo-
thelial migration, or migration across
a monolayer of endothelial cells, has
been defined in detail. Initially, tethering
is accomplished by interactions between
selectins on the apical surface of endothe-
lial cells and surface carbohydrates of the
PMN. PMNs then roll and are ultimately
arrested on the endothelial surface by
b2-integrin-mediated adhesion. Migration
then occurs either through an endothelial
cell, the transcellular route, or between
adjacent endothelial cells, the paracellular
route.
Transepithelial migration—which is
required for PMNs to cross the alveolar
epithelium of the lung, intestinal epithe-
lium of the gut, and tubular epithelium of
the kidney—occurs by processes similar
to transendothelial migration, although
there are several major differences (Ze-
mans et al., 2008). First, because PMNs
within the tissues have already crossed
the endothelium, they are, by definition,
at least partially activated before reach-
ing the epithelium. Second, because the
interstitial tissue the PMNs encounter
after leaving the vessels is relatively static,the initial tethering and rolling adhesive
interactions are unnecessary. In addition,
transepithelial migration occurs exclu-
sively via the paracellular route rather
than paracellular and transcellular routes,
as is the case in endothelium. There are
alsodifferences in thepolarity ofmigration,
as PMNs first encounter the apical
membrane of endothelial cells, while the
basolateral membrane is the initial site of
interaction with epithelium. Finally, selec-
tins (which are critical to early phases of
transendothelial migration) do not appear
to be involved in transepithelial migration,
and some PMN surface proteins, such
as CD44, enhance binding to endothelial
cells to enhancemigrationbut, conversely,
limit transepithelial migration. Despite
these differences, it is striking that many
surface adhesive molecules involved in
transendothelial migration are also impor-
tant to transepithelial migration.
From the perspective of the PMN, the
greatest distinction between endothelium
and epithelium may be the nature of
the junctions between adjacent cells. Inter-
cellular junctions between endothelial cells
are rather loose and, particularly when in-
flammatory mediators are present, readily
allow PMN transmigration. In contrast,
epithelial cells, which are charged with
maintaining a barrier separating internal
and external milieus, are joined to one
another via the tight junction. While tight
junctions may, in a tissue-specific manner,
allow ions and small solutes to pass
between cells, they normally exclude parti-
cles as large as cells. It has therefore been
suggested that PMN-derived signaling
molecules, oxidants, and proteases may
trigger local dissolutionof the tight junction.
While data supporting this hypothesis are
weak, it is noteworthy that PMNs tend to
cross in small groups, perhaps at sites
where the tight junction has been disrup-
ted. Transepithelial PMN migration alsoCell Host & Microbappears to preferentially occur at sites
where three epithelial cells meet: so-called
tricellular tight junctions, which have
a unique structure that may be amenable
to passage of cells (Burns et al., 2003).
However, the signaling events that ‘‘open’’
the tight junction to allow PMNs to pass
have not been previously defined.
In this issue, Chun and Prince shed
some light on the molecular mechanisms
by which pulmonary epithelial cells
accommodate paracellular PMN transmi-
gration (Chun and Prince, 2009). Their
work takes advantage of the observa-
tions, in experimental animals and human
subjects, that intrapulmonary instillation
of lipotechoic acid or lipopolysaccharide
(ligands for Toll-like receptor (TLR) 2 and
TLR4, respectively) results in rapid
recruitment of PMNs into the alveolar
space (Hoogerwerf et al., 2008). This has
been thought to be primarily due to direct
chemoattractant effects of bacterial prod-
ucts and the IL-8 released by airway
epithelium in response to TLR ligation
(Chun and Prince, 2006; Koff et al.,
2008). For example, ligation of TLR2,
which is expressed on the apical surface
of airway epithelia, triggers intracellular
Ca2+ release that leads to IL-8 secretion
(Chun and Prince, 2006). In the present
study, Chun and Prince hypothesized
that TLR2 ligation might also induce
airway epithelium to modulate their inter-
cellular junctions in order to facilitate
PMN transmigration. The authors show
that apical exposure of cultured airway
epithelial cells to heat-killed Pseudo-
monas aeruginosa or a synthetic TLR2
ligand caused marked decreases in tight
junction-associated occludin as well as
adherens junction-associated E-cad-
herin. TLR2 activation was associated
with activation of the intracellular Ca2+-
dependent protease calpain, and in vitro
analyses showed that calpain is ablee 5, January 22, 2009 ª2009 Elsevier Inc. 1
Cell Host & Microbe
Previewsto specifically degrade occludin and
E-cadherin. Consistent with the functional
importance of this calpain-dependent oc-
cludin and E-cadherin proteolysis, the
calpain inhibitor calpeptin markedly in-
hibited PMN migration across cultured
airway epithelium. The relevance of this
phenomenon was validated in vivo by
showing that Tlr2/ or calpeptin-treated
mice were deficient in airway PMN
recruitment induced by P. aeruginosa
infection. Consistent with the proposed
role of TLR2-dependent calpain activa-
tion, calpeptin treatment did not further
reduce PMN recruitment in Tlr2/ mice.
Thus, activation of TLR2 in airway epithe-
lium results in calpain-dependent modu-
lation of tight junction and adherens junc-
tion structure and facilitates PMN
transmigration (Figure 1).
Chun and Prince’s observations repre-
sent the first example in which epithelial
intercellular junctions are modified in
a manner that enhances transepithelial
migration of immune cells. It is likely that
this process also occurs in other epithelia,
although the details may differ at specific
sites, such as the gut, where some
tolerance to TLR ligands is required to
prevent an inappropriate response to the
intestinal microbiota. What is perhaps
even more surprising is the suggestion
that the tight junction protein occludin
may be involved in this process. Although
it was the first transmembrane tight junc-
tion protein discovered, the lack of an
obvious intestinal, renal, or pulmonary
epithelial phenotype in occludin/ mice
has caused many to question the impor-
tance of this protein (Saitou et al., 2000).
However, this is controversial, because
others have correlated specific endocy-
tosis of occludin with renal and intestinal2 Cell Host & Microbe 5, January 22, 2009 ªepithelial barrier dysfunction (Clayburgh
et al., 2005; Shen and Turner, 2005).
Nonetheless, the absence of a barrier
defect in occludin/ mice is consistent
with Chun and Prince’s observation that,
despite proteolysis of some occludin
and E-cadherin molecules, the barrier to
ion and solute flux created by airway
epithelia remains intact after TLR2 activa-
tion. One possible explanation is that oc-
cludin is most critical in restricting para-
cellular movement of large, cell-sized
objects.
In order to further our understanding of
the biological process discovered by
Chun and Prince, it may be fruitful for
future studies to ask whether epithelial
surface molecules known to be involved
Figure 1. Migration of PMNs into the
Alveolar Air Space
As described in the text, PMNs must first exit the
capillary before migrating across the alveolar
epithelium. In this issue, Chun and Prince (2009)
demonstrate that activation of apical TLR2 causes
increased intracellular Ca2+, calpain activation,
and degradation of the apical junctional complex
proteins occludin and E-cadherin. This facilitates
transepithelial PMN migration.2009 Elsevier Inc.in PMN transmigration are also modified
by TLR2 activation, and if ligands for other
TLRs are able to replace or enhance the
effects of TLR2 agonists. It would, for
example, be of interest to determine
whether lipopolysaccharide-mediated
TLR4 activation induces PMN transmigra-
tion by mechanisms that are similar to or
distinct from TLR2 ligands. Thus, while
questions remain, the observation that
TLR2 activation causes airway epithelia
to accommodate paracellular PMN mi-
gration revises the role of intercellular
junctions in this process from bystander
to active participant.
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